Immunological effects of BRAF+MEK inhibition
Author:
Affiliation:
1. Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori – IRCCS Fondazione “G. Pascale”, Napoli, Italy
2. Department of Dermatology, University Hospital Zürich Skin Cancer Center, Zürich, Switzerland
Funder
Novartis
Publisher
Informa UK Limited
Subject
Oncology,Immunology,Immunology and Allergy
Link
https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2018.1468955
Reference38 articles.
1. Meta-Analysis of Phase II Cooperative Group Trials in Metastatic Stage IV Melanoma to Determine Progression-Free and Overall Survival Benchmarks for Future Phase II Trials
2. Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
3. Survival of patients with advanced metastatic melanoma: the impact of novel therapies–update 2017
4. Progression-free survival landmark analysis: a critical endpoint in melanoma clinical trials
5. A systematic review and network meta-analysis of immunotherapy and targeted therapy for advanced melanoma
Cited by 65 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Innate Immune Cells in Melanoma: Implications for Immunotherapy;International Journal of Molecular Sciences;2024-08-05
2. Activation of the MAPK network provides a survival advantage during the course of COVID-19-induced sepsis: a real-world evidence analysis of a multicenter COVID-19 Sepsis Cohort;Infection;2024-06-19
3. Stroma-infiltrating T cell spatiotypes define immunotherapy outcomes in adolescent and young adult patients with melanoma;Nature Communications;2024-04-08
4. Efficacy and Safety of Triple Therapy in Advanced Melanoma — a Systematic Review and Network Meta-Analysis;2024
5. Survival of Patients With Primary Cutaneous Melanoma and the Surgical Treatment Option Based on the Level of the Surface Protein PD-L1 in the Tumor Tissue;Innovative Medicine of Kuban;2023-11-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3